Association between IL-1RN gene polymorphisms and susceptibility to ankylosing spondylitis: A large Human genome epidemiology review and meta-analysis

Genetics and Molecular Research

Volumn 12, Issue 2, 2013, Pages 1720-1730

  Jin, G X ^a   Duan, J Z ^a   Guo, W L ^a   Li, L ^a   Cui, S Q ^a   Wang, H ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Ankylosing spondylitis; Genetic polymorphisms; Interleukin 1 receptor antagonist; Meta analysis; Susceptibility

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ALLELE; ANKYLOSING SPONDYLITIS; ASIAN; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HUMAN; INTERLEUKIN 1 RECEPTOR ANTAGONIST GENE; MAJOR CLINICAL STUDY; PATHOGENESIS; REVIEW; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 84878166805     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.May.21.3     Document Type: Review

References (31)

1. Agrawal S, Srivastava R, Sharma B, Pandya S, et al. (2008). IL1RN*2 allele of IL-1receptor antagonist VNTR polymorphism is associated with susceptibility to ankylosing [corrected] spondylitis in Indian patients. Clin. Rheumatol. 27: 573-576.
2. Baek HJ, Shin KC, Lee YJ, Kang SW, et al. (2004). Clinical features of adult-onset ankylosing spondylitis in Korean patients: patients with peripheral joint disease (PJD) have less severe spinal disease course than those without PJD. Rheumatology 43: 1526-1531.
3. Baraliakos X, Listing J, Rudwaleit M, Sieper J, et al. (2008). The relationship between inflammation and new bone formation in patients with ankylosing spondylitis. Arthritis Res. Ther. 10: R104.
4. Braun J and Sieper J (2007). Ankylosing spondylitis. Lancet 369: 1379-1390.
5. Brown MA, Laval SH, Brophy S and Calin A (2000). Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann. Rheum. Dis. 59: 883-886.
6. Chou CT, Timms AE, Wei JC, Tsai WC, et al. (2006). Replication of association of IL1 gene complex members with ankylosing spondylitis in Taiwanese Chinese. Ann. Rheum. Dis. 65: 1106-1109.
7. Duan Z, Pan F, Zeng Z, Zhang T, et al. (2012). Interleukin-23 receptor genetic polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis. Rheumatol. Int. 32: 1209-1214.
8. El Maghraoui A (2011). Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur. J. Intern. Med. 22: 554-560.
9. Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, et al. (2003). Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol. Int. 23: 61-66.
10. Guo ZS, Li C, Lin ZM, Huang JX, et al. (2010). Association of IL-1 gene complex members with ankylosing spondylitis in Chinese Han population. Int. J. Immunogenet. 37: 33-37.
11. Higgins JP and Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat. Med. 21: 1539-1558.
12. Kim TH, Stone MA, Rahman P, Yoo DH, et al. (2005). Interleukin 1 and nuclear factor-kappaB polymorphisms in ankylosing spondylitis in Canada and Korea. J. Rheumatol. 32: 1907-1910.
13. Laval SH, Timms A, Edwards S, Bradbury L, et al. (2001). Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am. J. Hum. Genet. 68: 918-926.
14. Lin L, Chen WG and Hu FP (2006). Interleukin-1R and interleukin-1 receptor antagonist gene polymorphisms in Hu'nan Han nationoality ankylosing spondylitis patient. Clin. J. Rheumatol. 10: 726-728.
15. Liu H, Kong XD, Cai Q, Lu HQ, et al. (2008). The effect of single nucleotide polymorphism in interleukin-1 gene on the susceptibility of ankylosing spondylitis in Chinese Han population. Chin. J. Rheumatol. 12: 304-308.
16. Maksymowych WP, Reeve JP, Reveille JD, Akey JM, et al. (2003). High-throughput single-nucleotide polymorphism analysis of the IL1RN locus in patients with ankylosing spondylitis by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry. Arthritis Rheumatol. 48: 2011-2018.
17. Maksymowych WP, Rahman P, Reeve JP, Gladman DD, et al. (2006). Association of the IL1 gene cluster with susceptibility to ankylosing spondylitis: an analysis of three Canadian populations. Arthritis Rheumatol. 54: 974-985.
18. McGarry F, Neilly J, Anderson N, Sturrock R, et al. (2001). A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis. Rheumatology 40: 1359-1364.
19. Peloso PM, Gammaitoni A, Smugar SS, Wang H, et al. (2011). Longitudinal numbers-needed-to-treat (NNT) for achieving various levels of analgesic response and improvement with etoricoxib, naproxen, and placebo in ankylosing spondylitis. BMC Musculoskelet. Disord. 12: 165.
20. Perrier S, Darakhshan F and Hajduch E (2006). IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde? FEBS Lett. 580: 6289-6294.
21. Peters JL, Sutton AJ, Jones DR, Abrams KR, et al. (2006). Comparison of two methods to detect publication bias in metaanalysis. JAMA 295: 676-680.
22. Reveille JD (2006). Major histocompatibility genes and ankylosing spondylitis. Best. Pract. Res. Clin. Rheumatol. 20: 601-609.
23. Reveille JD, Sims AM, Danoy P, Evans DM, et al. (2010). Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat. Genet. 42: 123-127.
24. Sims AM, Timms AE, Bruges-Armas J, Burgos-Vargas R, et al. (2008). Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann. Rheum. Dis. 67: 1305-1309.
25. Stewart TL and Ralston SH (2000). Role of genetic factors in the pathogenesis of osteoporosis. J. Endocrinol. 166: 235-245.
26. Timms AE, Crane AM, Sims AM, Cordell HJ, et al. (2004). The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis. Am. J. Hum. Genet. 75: 587-595.
27. van der Paardt M, Crusius JB, Garcia-Gonzalez MA, Baudoin P, et al. (2002). Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis. Rheumatology 41: 1419-1423.
28. Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, et al. (2007). Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Epidemiology 18: 805-835.
29. Yang Y, Su ZW, Ma WS, Cai AJ, et al. (2007). Single nucleotide polymorphism of IL-1RN and TNF-α in ankylosing spondylitis. J. Trop. Med. 7: 948-951.
30. Zhang L, Liu JL, Zhang YJ and Wang H (2011). Association between HLA-B*27 polymorphisms and ankylosing spondylitis in Han populations: a meta-analysis. Clin. Exp. Rheumatol. 29: 285-292.
31. Zintzaras E and Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet. Epidemiol. 28: 123-137.